CD28 and Parkinson disease: Expression of the activation markers CD38 and HLA-DR on CD8+ T cells was not different between patients and controls, but expression of CD57 was reduced and expression of CD28 was increased in PD patients (Table 3; Fig. 1c), in keeping with the CD8+ subset data (Table 3; Fig. 1c).